Internal Medicine, Hematology & Oncology · Jacksonville, FL
NPI
1669734083
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4500 San Pablo Rd S
Jacksonville, FL, 32224
Phone (904) 953-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
618 services
Medicare patients, 2024
193
Average age 73
Drug cost, 2024
$16.2M
3,161 prescriptions
Company payments, 2025
$68K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arnab Basu was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 132 times for 79 patients. In total Arnab Basu billed 618 services in 13 codes, and Medicare paid $35K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 132 | 79 | $11.79 | $1,556 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 118 | 88 | $11.56 | $1,364 |
| 99215 Office E&M - Established | Office | 83 | 56 | $110.00 | $9,130 |
| 99214 Office E&M - Established | Facility | 83 | 63 | $57.87 | $4,803 |
| 99214 Office E&M - Established | Office | 72 | 50 | $63.60 | $4,579 |
| 99215 Office E&M - Established | Facility | 67 | 51 | $101.90 | $6,828 |
| 99205 Office E&M - New | Facility | 29 | 29 | $130.82 | $3,794 |
| 99205 Office E&M - New | Office | 15 | 15 | $146.51 | $2,198 |
By year: 2022 $47K for 564 services; 2023 $41K for 499 services; 2024 $35K for 618 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arnab Basu prescribed most often to Medicare patients was Abiraterone Acetate, with 258 prescriptions and refills. In total Arnab Basu wrote 3,161 Medicare prescriptions that cost $16.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 258 | 260 | 37 | $705K |
| Orgovyx Relugolix | 236 | 236 | 29 | $606K |
| Prednisone Generic | 235 | 241 | 46 | $797 |
| Xtandi Enzalutamide | 202 | 202 | 28 | $2.6M |
| Oxycodone Hcl Generic | 138 | 138 | 33 | $3,081 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 127 | 127 | 20 | $4,083 |
| Welireg Belzutifan | 122 | 122 | 20 | $3.1M |
| Lenvima Lenvatinib Mesylate | 121 | 121 | 26 | $2.8M |
| Nubeqa Darolutamide | 112 | 112 | 14 | $1.3M |
| Erleada Apalutamide | 93 | 93 | Under 11 | $1.2M |
| Eliquis Apixaban | 86 | 106 | 22 | $61K |
| Amlodipine Besylate Generic | 83 | 119 | 18 | $344 |
| Cabometyx Cabozantinib S-Malate | 80 | 80 | 12 | $1.6M |
| Ondansetron Odt Ondansetron | 79 | 79 | 33 | $1,657 |
| Inlyta Axitinib | 55 | 55 | Under 11 | $791K |
Brand drugs: 1,308 claims; generic drugs: 1,853 claims; opioid claims: 432.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arnab Basu $68K ($68K in general payments such as food, travel and fees) from 14 companies. The largest payer was Eisai Inc. with $41K.
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. 4523.T | 28 | $41K |
| EMD Serono, Inc. MRK.DE | 4 | $14K |
| Astellas Pharma US Inc 4503.T | 4 | $6,724 |
| Merck Sharp & Dohme LLC MRK | 3 | $4,115 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $1,600 |
| Aveo Pharmaceuticals, Inc. | 4 | $429 |
| Pfizer Inc. PFE | 2 | $366 |
| Janssen Biotech, Inc. JNJ | 1 | $146 |
| Telix Pharmaceuticals TLX | 1 | $146 |
| Exelixis Inc. EXEL | 1 | $134 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.